Shell Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$441K Buy
8,019
+3,060
+62% +$168K 0.02% 514
2025
Q1
$351K Buy
4,959
+176
+4% +$12.5K 0.02% 570
2024
Q4
$314K Buy
4,783
+2,268
+90% +$149K 0.01% 652
2024
Q3
$177K Buy
+2,515
New +$177K 0.01% 879
2024
Q1
$207K Sell
2,515
-145
-5% -$11.9K 0.01% 803
2023
Q4
$256K Sell
2,660
-1,187
-31% -$114K 0.01% 770
2023
Q3
$340K Buy
3,847
+351
+10% +$31K 0.01% 713
2023
Q2
$303K Sell
3,496
-7,587
-68% -$658K 0.01% 779
2023
Q1
$1.08M Hold
11,083
0.04% 351
2022
Q4
$1.15M Sell
11,083
-1,893
-15% -$196K 0.05% 340
2022
Q3
$1.1M Sell
12,976
-3,428
-21% -$291K 0.04% 356
2022
Q2
$1.36M Sell
16,404
-1,722
-10% -$143K 0.04% 368
2022
Q1
$1.4M Sell
18,126
-514
-3% -$39.6K 0.03% 400
2021
Q4
$1.65M Buy
18,640
+2,188
+13% +$193K 0.03% 405
2021
Q3
$1.27M Sell
16,452
-13,784
-46% -$1.07M 0.03% 435
2021
Q2
$2.52M Buy
30,236
+16,885
+126% +$1.41M 0.05% 321
2021
Q1
$1.01M Sell
13,351
-17,129
-56% -$1.29M 0.02% 536
2020
Q4
$2.67M Buy
30,480
+21,473
+238% +$1.88M 0.06% 334
2020
Q3
$685K Sell
9,007
-227
-2% -$17.3K 0.02% 561
2020
Q2
$1.14M Sell
9,234
-12,270
-57% -$1.51M 0.03% 417
2020
Q1
$1.82M Sell
21,504
-500
-2% -$42.2K 0.05% 320
2019
Q4
$1.86M Buy
22,004
+4,695
+27% +$397K 0.04% 385
2019
Q3
$1.17M Hold
17,309
0.03% 476
2019
Q2
$1.48M Sell
17,309
-1,400
-7% -$120K 0.03% 426
2019
Q1
$1.66M Buy
18,709
+2,531
+16% +$225K 0.04% 384
2018
Q4
$1.38M Sell
16,178
-6,558
-29% -$559K 0.03% 408
2018
Q3
$2.21M Sell
22,736
-622
-3% -$60.3K 0.04% 365
2018
Q2
$2.2M Buy
23,358
+653
+3% +$61.5K 0.05% 382
2018
Q1
$1.84M Sell
22,705
-52
-0.2% -$4.22K 0.04% 418
2017
Q4
$2.03M Buy
22,757
+3,042
+15% +$271K 0.04% 394
2017
Q3
$1.84M Sell
19,715
-2,317
-11% -$216K 0.04% 389
2017
Q2
$2M Sell
22,032
-467
-2% -$42.4K 0.04% 387
2017
Q1
$1.98M Sell
22,499
-2,085
-8% -$183K 0.04% 374
2016
Q4
$2.04M Sell
24,584
-1,213
-5% -$101K 0.05% 386
2016
Q3
$2.39M Sell
25,797
-1,618
-6% -$150K 0.05% 368
2016
Q2
$2.13M Buy
27,415
+5,179
+23% +$403K 0.05% 364
2016
Q1
$1.83M Buy
22,236
+344
+2% +$28.4K 0.04% 398
2015
Q4
$2.29M Sell
21,892
-6,953
-24% -$728K 0.05% 342
2015
Q3
$2.08M Buy
28,845
+909
+3% +$65.6K 0.03% 454
2015
Q2
$3.82M Buy
27,936
+656
+2% +$89.7K 0.08% 263
2015
Q1
$3.4M Sell
27,280
-7,514
-22% -$936K 0.06% 304
2014
Q4
$3.15M Buy
34,794
+5,949
+21% +$538K 0.05% 338
2014
Q3
$2.08M Sell
28,845
-5,509
-16% -$397K 0.03% 468
2014
Q2
$2.14M Buy
34,354
+550
+2% +$34.2K 0.03% 464
2014
Q1
$2.31M Sell
33,804
-3,720
-10% -$254K 0.04% 441
2013
Q4
$2.64M Sell
37,524
-16,162
-30% -$1.14M 0.04% 389
2013
Q3
$3.88M Sell
53,686
-4,212
-7% -$304K 0.07% 287
2013
Q2
$3.23M Buy
+57,898
New +$3.23M 0.06% 313